<DOC>
	<DOCNO>NCT01054222</DOCNO>
	<brief_summary>This open-label extension study intend subject previously complete study A0221045 ( fesoterodine elderly OAB patient ) recommend investigator suitable extend use Fesoterodine . Data study extend evaluation efficacy , tolerability safety Fesoterodine old subject Portugal .</brief_summary>
	<brief_title>Local , Open-Label , Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Subjects must previously complete fesoterodine study A0221045 [ Portugal ] Subjects must recommend inclusion investigator Conditions state exclude use fesoterodine e.g . contraindication fesoterodine Predominant stress incontinence determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>overactive bladder idiopathic</keyword>
	<keyword>elderly fesoterodine SOFIA Portugal extension study</keyword>
</DOC>